Polifarma and Amino sign agreement on Uridine

Polifarma (Rome-Italy) and Amino ((Frellstedt-Germany) sign a licensing agreement for the use of uridine in nutrition and pharmaceutical applications worldwide. The mutual strategy has Amino driving the global marketing efforts with focus on the US nutrition market, supported by Polifarma's technical and scientific expertise.

POLIFARMA and AMINO SIGN URIDINE LICENSING AGREEMENT

Rome, august 9, 2002.
Polifarma is proud to announce their new patnership with Amino of Frellstedt (Germany). Amino and Polifarma
have signed a licensing agreement for the use of uridine in nutrition and pharmaceutical applications worldwide.
The mutual strategy has Amino driving the global marketing efforts with focus on the US nutrition market supported
by Polifarma's technical and scientific expertise. Both companies have been studying the amazing benefits of uridine
for years", says Lutz Thomas, Head of Sales and Marketing for Amino. With this alliance, we'll be able to bring
those benefits to the global nutrition and pharma markets". Uridine has been shown to be effective in the treatment
of cognitive health and neurodegenerative disorders, depression, pain, joint health and arthritis, osteoporosis and
sports performance. The list of benefits and applications continues to grow with research and development.

Polifarma S.p.A. is a pharmaceutical company with offices and research facilities on the eastern edge of Rome,
Italy. Polifarma, an important partner for doctors and institutions, makes a variety of therapeutic and
pharmaceutical products with a concentration in cardiovascular, CNS and antibiotics. Polifarma works with
several academic groups on innovative research projects in several countries. Polifarma and their parent company,
Final S.p.A., are working to secure steady growth in the italian market through the selection of specific therapeutic
areas and the establishment of strategic alliances with a few international partners.

Amino Gmbh, headquartered in Frellstedt, Germany, is a fully integrated producer of Amino Actives, which
include amino acids and other value-added ingredients with natural biological origins. The company is dedicated to
high-quality practices and state-of-the-art manufacturing processes in the production of active pharmaceutical-grade
and nutritional compounds. Amino active products, derived primarily from beet sugar molasses and other
vegetable sources, are produced according to international GMP standards.